|Ms. Louisa S. Burdett BSc Hons, ACA||Group Fin. Director & Exec. Director||395.04k||N/A||N/A|
|Mr. Timothy J. Cooper||Exec. Director of Industrial & Exec. Director||N/A||N/A||N/A|
|Dr. Martin L. Court||Exec. Director of Medical & Exec. Director||329.04k||N/A||1962|
|Mr. Jakob O. Sigurdsson BA, MBA||CEO & Exec. Director||N/A||N/A||1964|
|Mr. Andrew Hanson||Director of Investor Relations & Corp. Communications||N/A||N/A||N/A|
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers. It serves automotive, aerospace, energy, manufacturing and engineering, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.
Victrex plc’s ISS Governance QualityScore as of April 1, 2018 is 7. The pillar scores are Audit: 9; Board: 8; Shareholder Rights: 1; Compensation: 5.